Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Asset Utilization Ratio (2021 - 2025)

Historic Asset Utilization Ratio for Rani Therapeutics Holdings (RANI) over the last 5 years, with Q3 2025 value amounting to 0.09.

  • Rani Therapeutics Holdings' Asset Utilization Ratio rose 39885.66% to 0.09 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.09, marking a year-over-year increase of 39885.66%. This contributed to the annual value of 0.02 for FY2024, which is N/A changed from last year.
  • Latest data reveals that Rani Therapeutics Holdings reported Asset Utilization Ratio of 0.09 as of Q3 2025, which was up 39885.66% from 0.06 recorded in Q2 2025.
  • Rani Therapeutics Holdings' 5-year Asset Utilization Ratio high stood at 0.09 for Q3 2025, and its period low was 0.08 during Q4 2023.
  • Over the past 5 years, Rani Therapeutics Holdings' median Asset Utilization Ratio value was 0.0 (recorded in 2022), while the average stood at 0.0.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 48957.92% in 2024, then skyrocketed by 39885.66% in 2025.
  • Quarter analysis of 5 years shows Rani Therapeutics Holdings' Asset Utilization Ratio stood at 0.02 in 2021, then decreased by 21.3% to 0.02 in 2022, then crashed by 583.89% to 0.08 in 2023, then surged by 132.36% to 0.03 in 2024, then skyrocketed by 246.15% to 0.09 in 2025.
  • Its Asset Utilization Ratio stands at 0.09 for Q3 2025, versus 0.06 for Q2 2025 and 0.04 for Q1 2025.